BlackRock Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$54,618,236
-4.4%
2,137,700
+7.3%
0.00%0.0%
Q2 2023$57,137,302
+32.7%
1,992,235
+10.9%
0.00%
+100.0%
Q1 2023$43,057,718
+34.7%
1,796,317
-4.7%
0.00%0.0%
Q4 2022$31,967,647
+10.0%
1,884,885
-3.9%
0.00%0.0%
Q3 2022$29,056,000
-3.1%
1,960,589
+3.0%
0.00%0.0%
Q2 2022$29,973,000
-34.4%
1,904,302
+12.3%
0.00%0.0%
Q1 2022$45,715,000
-29.8%
1,695,639
-3.6%
0.00%
-50.0%
Q4 2021$65,121,000
-20.8%
1,759,590
+2.3%
0.00%0.0%
Q3 2021$82,216,000
+42.6%
1,720,708
+1.0%
0.00%0.0%
Q2 2021$57,647,000
-20.4%
1,703,509
-2.8%
0.00%0.0%
Q1 2021$72,383,000
-6.4%
1,752,604
-1.6%
0.00%0.0%
Q4 2020$77,301,000
+55.0%
1,781,955
+53.3%
0.00%0.0%
Q3 2020$49,859,000
+10.7%
1,162,228
+20.6%
0.00%0.0%
Q2 2020$45,028,000
+4288.7%
963,362
+1177.3%
0.00%
Q1 2020$1,026,000
+49.6%
75,424
+19.5%
0.00%
Q4 2019$686,000
+6.7%
63,094
+0.9%
0.00%
Q3 2019$643,000
+189.6%
62,550
+165.6%
0.00%
Q2 2019$222,00023,5480.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2022
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders